LEAMON CHRISTOPHER P (Vice President of Research) sold 6.9% of their position (9.03K shares) of ENDOCYTE INC on the open market
Open‑market sale worth $140.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/9/2018ACC: 0001179110-18-012091
Officer· Vice President of Research
Since Aug 2018
-9.03K
Net shares
Net seller
$140.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.03K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.03K
Price / share
$15.56
Trade value
$140.44K
% of position
6.9%
10/5/2018
130.38K→121.35K
Total
Net shares
−9.03K
Net value
-$140.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/5/2018 | S · Sale | −9.03K | $15.56 | $140.44K | 6.9% | 130.38K | 121.35K |
| Total | −9.03K | -$140.44K | ||||||
Derivative Transactions0
No derivative transactions reported